- Home
- SCLX vs AXIL Comparison
SCLX vs AXIL Comparison
Compare SCLX & AXIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SCLX
- AXIL
- Stock Information
- Founded
- SCLX 2011
- AXIL 2015
- Country
- SCLX United States
- AXIL United States
- Employees
- SCLX N/A
- AXIL N/A
- Industry
- SCLX Biotechnology: Pharmaceutical Preparations
- AXIL Package Goods/Cosmetics
- Sector
- SCLX Health Care
- AXIL Consumer Discretionary
- Exchange
- SCLX Nasdaq
- AXIL Nasdaq
- Market Cap
- SCLX 35.7M
- AXIL 37.1M
- IPO Year
- SCLX N/A
- AXIL N/A
- Fundamental
- Price
- SCLX $26.28
- AXIL $7.00
- Analyst Decision
- SCLX Strong Buy
- AXIL
- Analyst Count
- SCLX 3
- AXIL 0
- Target Price
- SCLX $367.50
- AXIL N/A
- AVG Volume (30 Days)
- SCLX 230.4K
- AXIL 24.2K
- Earning Date
- SCLX 08-13-2025
- AXIL 10-09-2025
- Dividend Yield
- SCLX N/A
- AXIL N/A
- EPS Growth
- SCLX N/A
- AXIL N/A
- EPS
- SCLX N/A
- AXIL 0.10
- Revenue
- SCLX $44,236,000.00
- AXIL $26,257,522.00
- Revenue This Year
- SCLX $89.26
- AXIL N/A
- Revenue Next Year
- SCLX $203.95
- AXIL N/A
- P/E Ratio
- SCLX N/A
- AXIL $70.00
- Revenue Growth
- SCLX N/A
- AXIL N/A
- 52 Week Low
- SCLX $3.60
- AXIL $3.54
- 52 Week High
- SCLX $41.30
- AXIL $10.75
- Technical
- Relative Strength Index (RSI)
- SCLX 76.74
- AXIL 54.01
- Support Level
- SCLX $23.90
- AXIL $4.44
- Resistance Level
- SCLX $19.73
- AXIL $8.00
- Average True Range (ATR)
- SCLX 1.85
- AXIL 0.95
- MACD
- SCLX 0.50
- AXIL 0.12
- Stochastic Oscillator
- SCLX 91.79
- AXIL 71.91
About SCLX Scilex Holding Company
Scilex Holding Co is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system), is a prescription lidocaine topical product for relieving pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It is focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. The Company's three product candidates are SP-102 or SEMDEXA viscous gel formulation of a used corticosteroid for epidural injections, SP-103 a Phase 2, triple-strength formulation of ZTlido, and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule.
About AXIL AXIL Brands Inc. Common Stock
AXIL Brands Inc is a company which is is a manufacturer and marketer of premium hearing enhancement and protection products, including ear plugs, earmuffs, and ear buds, and outdoor speakers, under the AXIL brand. AXIL delivers top hearing enhancement, protection, & audio devices. From ultra comfortable fitting processes, to stereo quality sound performance, to reliable & durable engineering. The company operates two operating segments: hearing enhancement and protection, and hair and skin care.